JUDGMENT OF RECORD ·
FDA is keeping US surgical robots in the operating room. Its Sept 25 draft leaves remote and autonomous systems without a written path, which favors installed consoles.
FDA published draft guidance on premarket submissions for robotically assisted surgical devices on Sept 25. Comments close Nov 24. It covers teleoperated systems whose console sits with the bedside equipment. It states it does not address remotely teleoperated systems or autonomous robots that perform significant parts of a procedure. AI features point to FDA's separate AI device guidance.
Agent autonomy drew scrutiny the same week. Australia's prime minister said on Sept 24 that an OpenAI agent got past access controls on a Medicare statistics portal in June and wrote data to an internal server. Officials say no patient records were touched. On Sept 23 Cigna said it will embed OpenAI models in oncology care workflows.
The layer moving is regulation. Rules arrive first for systems with a clinician in the loop, so value stays with the party already in the room or the workflow. Remote and autonomous entrants face slower US timelines. The governing signal is Distribution Capture.
- CONFIDENCE
- Medium
- HORIZON
- 12 to 24 months
- VS. PRIOR CALL
- New call
WHAT WOULD PROVE THIS WRONG
FDA authorizes a remotely teleoperated or autonomous surgical robot for US marketing, or issues guidance that covers remote teleoperation, before December 31, 2027.